Novo Nordisk Research Centre Oxford (NNRCO)

photo (c) John Cairns

Conducting cutting edge research at Oxford (photo: John Cairns)

Ground-breaking research in Oxford

Novo Nordisk Research Centre Oxford is an innovative target discovery and translational research unit with a focus on identifying novel, game-changing therapies for patients with type 2 diabetes and cardiometabolic diseases.

We employ advanced computational biology, state-of-the-art discovery screening technologies, genetics and human-centric cell systems to dissect pathophysiology and identify novel drug targets. The site is a fusion of the best of academia, biotech and big pharma in order to realize cutting-edge biology and start a target’s journey from bench to bedside.

NNRCO is one of our three transformational research units, operating at the boundaries of frontier science with a mandate to find dynamic, agile and distinctive new ways of working to diversify the company’s pipeline with disruptive medicines.

Oxford Research Centre, Innovation Building, Old Road Campus, University of Oxford

Oxford Research Centre, Innovation Building, Old Road Campus, University of Oxford

Our Oxford research partnerships

Our Research Centre Oxford continuously looks for partners with expertise in type 2 diabetes and cardiometabolic diseases, from novel modalities to technologies, in early research to clinical stage.

We are interested in academic and industrial partners who use disruptive technologies to challenge traditional ways of thinking and benefit unmet patient needs. We offer partners our disease understanding, human-centric scientific models, state-of-the-art technologies and tailored collaborations.

Contact us to engage with us: NNRCOinfo@novonordisk.com.

A career at Oxford

We describe ourselves as collaborative, dedicated and ambitious, with an innovative science-oriented approach to drive change to improve patient’s lives. We are a diverse group with backgrounds in bioinformatics, genetics, disease biology, technology and drug discovery.

Our workplace values and culture are spelled out in The Novo Nordisk Way.

Visit our careers page to find opportunities to join our team.

photo (c) John Cairns

In silico drug target identification at NNRCO (photo: John Cairns)

Fellowship programme

Our Oxford Fellowship Programme is run in close collaboration with the University of Oxford.

The programme supports the development of a new generation of exceptional diabetes and metabolism researchers, who will become future leaders in the field, while further advancing scientific excellence within diabetes and cardiometabolic diseases.

The programme has approximately five highly competitive research and clinical research training fellow positions available each year. 

Visit the programme website for open positions and to learn more about current and past fellows.

photo (c) John Cairns

Proteomics lab at NNRCO (photo: John Cairns)

Meet our research teams

Our Research Centre Oxford currently has four research teams onsite, working together to solve complex scientific challenges using human genetics, big data and cutting-edge technologies. The Oxford site drives in house discovery efforts with external collaborators, in partnership with other Novo Nordisk international sites. The global collaboration contributes to our overall pipeline and to greater scientific understanding to help solve unmet needs in the diabetes and cardiometabolic fields.

Meet our research teams

Dr. Bill Haynes

Dr. Bill Haynes

Dr. Bill Haynes

Dr. Bill Haynes has been the site head of Novo Nordisk Research Centre Oxford since December 2018. Bill is a physician-scientist with more than 20 years of experience in academic-industry translational research across cardio-metabolic diseases.

Contact us

Contact us

Novo Nordisk Research Centre Oxford